In Recognition of Lung Cancer Awareness Month

Best Practices in Lung Cancer – November 2017 Vol 8 —November 15, 2017
Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG
Editor-in-Chief, JONS; Co-Founder, AONN+; University Distinguished Service Professor of Breast Cancer, Professor of Surgery, Johns Hopkins University School of Medicine; Co-Developer, Work Stride-Managing Cancer at Work, Johns Hopkins Healthcare Solutions

Dear Navigators,

The principles of navigation began in the discipline of breast cancer. After observing the tremendous success of removing barriers to care as an effective method to improve clinical outcome and patient satisfaction, navigation tactics have been incorporated into many oncology disciplines. In this Special Edition, we direct our attention to lung cancer and the positive impact navigators have had in this disease state.

Lung cancer is a field in which great strides have been made over the past decade. From smoking cessation programs to the introduction of immunotherapy to the development and implementation of lung nodule screening, patients living with lung cancer have more treatment options and lifestyle-enhancing services available to them than ever before.

In this issue, we present an interview with Wendy Brooks, RN, ONN-CG(T), a thoracic nurse navigator at the HCA Midwest Research Medical Center, about her typical, or not so typical, day as a navigator. We are pleased to present an article by Amy M. Norton, RN, MSN, ONN-CG(T), and colleagues entitled “Lung Cancer. Now What? Plans and How We ‘Navigate’ Them.” We also bring you news in lung cancer from the European Society for Medical Oncology 2017 Congress.

It is our hope that this issue is a valuable resource to the nurse and patient navigators who work tirelessly to help their patients living with lung cancer. Thank you for all you do for your patients and for your valued and loyal readership.

Sincerely,

Lillie Digital Signature

Lillie D. Shockney, RN, BS, MAS, ONN-CG
Editor-in-Chief, JONS; Program Director, AONN+

University Distinguished Service Professor of Breast Cancer; Administrative Director, the Johns Hopkins Breast Center; Director, Cancer Survivorship Programs at the Sidney Kimmel Cancer Center at Johns Hopkins; Professor, JHU School of Medicine, Depts of Surgery and Oncology; Cofounder, Johns Hopkins Medicine Managing Cancer at Work.
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

Related Articles
Biomarker Testing Access Varies for Patients with Advanced NSCLC
Web Exclusives
Biomarker testing is associated with improved overall survival in patients with advanced non–small-cell lung cancer, but disparities in access to testing persist.
Therapies in Development for KRAS G12C–Mutated NSCLC
Web Exclusives
A review of treatments and clinical studies for non–small-cell lung cancer harboring the KRAS G12C mutation finds encouraging overall survival results.
Palliative Care in Patients with Advanced NSCLC Varies Among Racial/Ethnic Groups and Insurance Providers
Web Exclusives
Palliative care is underused by Black and Hispanic/Latinx patients with advanced non–small-cell lung cancer.
Last modified: November 15, 2022

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country